Treatment strategy of chemotherapy for unresectable metastatic or recurrent colorectal cancer
Iwasa, S.; Shimada, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 427-432
2011
ISSN/ISBN: 0047-1852 PMID: 22213999 Document Number: 654773
Document emailed within 1 workday
Related Documents
Arakawa, S.; Horiguchi, A.; Tomishige, H.; Kawabe, N.; Nagata, H.; Ishihara, S.; Ito, M.; Asano, Y.; Ito, R.; Isetani, M.; Shimizu, K.; Kamio, K.; Kawai, T.; Yasuoka, H.; Imaeda, Y. 2018: Safety and Efficacy of TAS-102 with Bevacizumab for the Treatment of Unresectable Metastatic Colorectal Cancer - A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(4): 649-651Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Sasaki, K.; Takasaka, H.; Nishikawa, N.; Yoshikawa, T.; Hirata, K. 2003: Home chemotherapy and outpatient treatment for metastatic colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 7): 333-337
Klotz, H.P.; Weder, W.; Largiadèr, F. 1993: Local and systemic toxicity of intra-hepato-arterial chemotherapy for treatment of unresectable liver metastases of colorectal cancer with 5-Fluorouracil and high dose Leucovorin Helvetica Chirurgica Acta 60(1-2): 283-286
Matsumoto, R.; Kuroda, T.; Yamada, H.; Hasegawa, K.; Mamiya, Y.; Kon, A. 2009: Chemotherapy with bevacizumab (BV)+modified FOLFOX6 for unresectable colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2207-2209
An, M.; Matsumoto, Y.; Kishi, T.; Terakado, H.; Ikawa, M.; Hamada, E.; Watanabe, Y.; Nakasato, S.; Murata, M.; Takaki, S.; Miura, T.; Idezuki, Y.; Kobayashi, M. 1998: Intra-arterial infusion chemotherapy for unresectable or recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(9): 1330-1332
Yoshimura, K.; Hazama, S.; Iizuka, N.; Takano, N.; Matsuoka, K.; Tangoku, A.; Oka, M. 2002: Hepatic arterial infusion of IL-2 and chemotherapy for unresectable liver metastasis from colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(12): 2117-2120
Sukaraphat, N.; Chewaskulyong, B.; Buranapin, S. 2016: Dietary Counseling Outcomes in Locally Advanced Unresectable or Metastatic Cancer Patients Undergoing Chemotherapy Journal of the Medical Association of Thailand 99(12): 1283-1290
Kobayashi, H.; Uetake, H.; Higuchi, T.; Enomoto, M.; Iida, S.; Ishikawa, T.; Ishiguro, M.; Kato, S.; Matsuyama, T.; Ono, H.; Yamauchi, S.; Masuda, D.; Sugihara, K. 2011: Repeated resections for originally unresectable liver metastasis from colorectal cancer after multiagent chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(12): 2301-2303
Fukunaga, M.; Takatsuka, Y.; Hasegawa, S.; Yongman, K.; Kondo, M.; Hirao, T.; Kan, K.; Tono, T.; Ohzato, H.; Imamoto, H.; Yamazaki, K.; Maruyama, H. 1998: Intra-arterial chemotherapy to improve quality of life in cases of unresectable advanced or recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(9): 1341-1343
Shitara, K.; Munakata, M.; Kudo, T.; Kasai, M.; Muto, O.; Okada, R.; Mitobe, S.; Ishiguro, A.; Sakuraba, H.; Ikami, I.; Sakata, Y. 2006: Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(13): 2033-2037
Muro, K. 2013: Team medicine in chemotherapy for metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(4): 435-439
Kamnerdsupaphon, P.; Lorvidhaya, V.; Chitapanarux, I.; Tonusin, A.; Sukthomya, V. 2007: FOLFIRI chemotherapy for metastatic colorectal cancer patients Journal of the Medical Association of Thailand 90(10): 2121-2127
Watanabe, T.; Sawada, T.; Kubota, Y.; Ooya, M.; Masaki, T.; Sameshima, S.; Shinozaki, M.; Tsuno, N.; Uchiyama, M.; Sakaguchi, M. 1992: Continuous intra-arterial infusion chemotherapy in colorectal cancer patients with nonresectable metastatic liver cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(10 Suppl): 1515-1518
Conroy, T.; Marchal, F.; Briançon, S. 2000: Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer New England Journal of Medicine 342(20): 1525; Author Reply 1526-1527
Takiuchi, H. 2011: Efficacy of monoclonal antibodies in combination with chemotherapy in metastatic colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 459-463
Gebbia, V.; Zerillo, G.; Gebbia, N.; Agostara, B.; Callari, A.; Rausa, L. 1992: Chemotherapy in head and neck cancer (I): Management of recurrent or metastatic disease Journal of Chemotherapy 4(4): 244-259
Koukourakis, G.; Kouloulias, V.; Zacharias, G.; Koukourakis, M. 2010: Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy Journal of Buon: Official Journal of the Balkan Union of Oncology 15(4): 652-659
Ide, Y.; Mikami, K.; Murata, K. 2009: Intermittent hepatic arterial infusion with systemic chemotherapy for metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2172-2174
Soga, Y.; Ito, D.; Asano, H.; Go, M.; Iwai, M.; Okada, K.; Matsuoka, T.; Adachi, S.; Usami, E.; Kimura, M.; Nakao, T.; Yoshimura, T.; Yasuda, T.; Ogawa, T.; Iwaki, A. 2013: Continuation of chemotherapy with bevacizumab for advanced and recurrent colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(10): 1341-1345